VentriPoint Diagnostics Ltd V.VPT

RE:RE:RE:RE:RE:RE:Catalyst LIVE, at Stanford Children's and Couty County Hospi

[jopatclo]

jopatclo wrote:

jopatclo wrote: Very exciting news yesterday from Ascend...

[Chicago, IL January 16,2023] – ASCEND Cardiovascular’s newest technology, Catalyst LIVE, currently implemented at two pioneering hospital sites, has pilots underway since 2022 at Stanford Medicine Children’s Health in California and Cook County Health in Illinois. Catalyst LIVE has prompted the expansion of this innovative technology into additional areas and campuses at these pilot sites giving their teams access to state-of-the-art technology, enabling more patients to benefit from expert insights and timely decisions.

ASCEND CardiovascularASCEND Cardiovascular 964 abonns964 abonns 1 mois • 1 mois • We are excited to announce that we will now be distributing Ventripoint Diagnostics Ltd.'s AI-powered heart-scanning technology as an integrated product of our imaging solutions. is now a part of ASCEND Cardiovascular‘s global distribution and marketing for cardiac diagnostic and imaging technologies. Ventripoint’s AI-powered diagnostic technology will be integrated into ASCEND Cardiovascular‘s IT for cardiovascular care for its current user base of over 50,000 hospitals and clinics. The collaboration marks a significant stepping stone for providing access to advanced care for patients and families.

thank you anonymous for selling me your shares :-) I'm a buyer even if my average goes up...from $.21 to now almost $.235...I've been long for several years so go pass the .64 tik..tak..news coming $$
Nice Chart see go pass 0.64nbsp;with the news 1) conclusion of sales, 2) announcement of 4.0 finalization, 3) further Ascend update and 4) new partnership 5) conclusion of various 3rd party studies/trails. 6)Edison... Well done, Dr. Alvira and Dr. George Adams, continue your great work for our children. From Jeffrey Soble, MD, President & CEO of ASCEND: “Our aim is to provide clinicians with reliable and effective tools on a global scale.” Stay tuned for more updates on this exciting collaboration!
imple Moving Avg (30) ——Simple Moving Avg (90) ——Simple Moving Avg (200) ——

good comment and the patience and our trust of Dr. G.Adams for this great and unique tectonolgy for the health of our children for several years with Ventripoint the long ones.... the reward for our investment and even more now for the health of everywhere in the world is now $$$ Well done to all...even the FUDS one day will be happy for the success of Ventripoint for them or one of their loved ones...

@Samburns level 2 looks thin up to .355 now

 

3

about 2 hours ago

 

@Rocket67 @TonyTwoShoes I think this is a good opportunity through end of March but that is just me. Based on the planned launch of 4.0 with Ascend, I believe that their "big splash" will be at the ASE24 in April, which they already are on the roster. I think it's funny that Alvira used the term "big splash" for the Ascend launch when Dr. Adams used the exact same term for the GEHC launch that failed to get off the launch pad. Let's hope things go much better this time.

 

3

about 2 hours ago

 

@Rocket67 VMS 4.0+ has been on the horizon for VPT for several years, I know at least since before 2021. To have this submitted for FDA/regulatory approvals is a huge deal, bigger than most understand. They have not rushed this to market, it was developed until it was ready. Folks that have been hearing about this for years are finally going to see it being marketed by Ascend THIS YEAR and likely early in Q2. This is the version that they planned on selling, 3.0 was a stepping stone. Once this is released you will see more PO's being invoiced and revenue start coming in. 2024 is the year this gets moving!! Time to start accumulating while it's still under a buck.

 

10

about 2 hours ago

 

@yudi Alvira stated "Our time is now! This is the only time you have heard me say this!" Look for big IDN news, hospital sales, 4.0, Ascend roll out, Edison, new partnership. Just the 4.0 alone is worth more than the dollard $$$. Go Dr.G.Adams the visionary and Dr.Alvira to silence the bashers on Ventripoint $$$

@Samburns level 2 looks thin up to .355 now

 

3

about 2 hours ago

 

@Rocket67 @TonyTwoShoes I think this is a good opportunity through end of March but that is just me. Based on the planned launch of 4.0 with Ascend, I believe that their "big splash" will be at the ASE24 in April, which they already are on the roster. I think it's funny that Alvira used the term "big splash" for the Ascend launch when Dr. Adams used the exact same term for the GEHC launch that failed to get off the launch pad. Let's hope things go much better this time.

 

3

about 2 hours ago

 

@Rocket67 VMS 4.0+ has been on the horizon for VPT for several years, I know at least since before 2021. To have this submitted for FDA/regulatory approvals is a huge deal, bigger than most understand. They have not rushed this to market, it was developed until it was ready. Folks that have been hearing about this for years are finally going to see it being marketed by Ascend THIS YEAR and likely early in Q2. This is the version that they planned on selling, 3.0 was a stepping stone. Once this is released you will see more PO's being invoiced and revenue start coming in. 2024 is the year this gets moving!! Time to start accumulating while it's still under a buck.

 

10

about 2 hours ago

 

@yudi Alvira stated "Our time is now! This is the only time you have heard me say this!" Look for big IDN news, hospital sales, 4.0, Ascend roll out, Edison, new partnership. Just the 4.0 alone is worth more than the dollard $$$. Go Dr.G.Adams the visionary and Dr.Alvira to silence the bashers on Ventripoint $$$